Bioscience

Biozona Weekly: UA research building; Hospital gift; Paradigm trial

May 16, 2014

By Flinn Foundation

Indiana University, Paradigm conducting trial using NGS to direct therapy for TNBC patients
5/16/14 | Genome Web | Staff Report

Paradigm, a spinoff of International Genomics Consortium in Phoenix, will use next-generation sequencing to analyze the tumor profiles of Indiana University study participants to develop direct personalized treatment strategies for women with breast cancer.

University of Arizona plans research building downtown
5/15/14 | Arizona Republic | Anne Ryman

The University of Arizona and city of Phoenix announced plans for a 10-story, $136-million research building–the Biosciences Partnership Building–on the downtown Phoenix Biomedical Campus that will help the university move forward in the biomedical sciences. Read also: University of Arizona to build $136M medical research building in downtown Phoenix

St. Joseph’s opens hospital in Glendale
5/15/14 | KTAR | Lauren Berkley

The 60,000-square-foot St. Joseph’s Westgate Medical Center, a full-service facility that can serve orthopedic, urology, endoscopy and gastrointestinal patients, has opened in Glendale.

UA Tech Park inspires local youth in STEM education fields

5/14/14 | Arizona Public Media | Jackie Abad

Tech Parks Arizona won the Metropolitan Education Commission’s (MEC) Crystal Apple Award for inspiring local youth to study the fields of science, technology, engineering and mathematics career paths.

St. Joseph’s Hospital secures $19 million gift
5/13/14 | Arizona Republic | Ken Alltucker

St. Joseph’s Hospital’s foundation secured a $19 million donation from Valley philanthropist John Norton–the largest in the hospital’s history–to start a new unit for lung, heart and esophageal medicine and research.

Business Briefs: Yelton leaving NACET for Phoenix
5/11/14 | Arizona Daily Sun | Staff Report

Russ Yelton, Northern Arizona Center for Entrepreneurship and Technology’s president and CEO since 2009, is leaving to assume the role of chief executive officer for Pinnacle Transplant Technologies, a biologics company in Phoenix.